Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.02
MDAS's Cash to Debt is ranked lower than
99% of the 1754 Companies
in the Global Health Information Services industry.

( Industry Median: 20.60 vs. MDAS: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
MDAS' s 10-Year Cash to Debt Range
Min: 0  Med: 0.05 Max: N/A
Current: 0.02
Equity to Asset 0.27
MDAS's Equity to Asset is ranked lower than
88% of the 1549 Companies
in the Global Health Information Services industry.

( Industry Median: 0.61 vs. MDAS: 0.27 )
Ranked among companies with meaningful Equity to Asset only.
MDAS' s 10-Year Equity to Asset Range
Min: -0.6  Med: 0.28 Max: 0.61
Current: 0.27
-0.6
0.61
Interest Coverage 1.02
MDAS's Interest Coverage is ranked lower than
97% of the 1143 Companies
in the Global Health Information Services industry.

( Industry Median: 10000.00 vs. MDAS: 1.02 )
Ranked among companies with meaningful Interest Coverage only.
MDAS' s 10-Year Interest Coverage Range
Min: 0.59  Med: 1.38 Max: 9999.99
Current: 1.02
0.59
9999.99
F-Score: 5
Z-Score: 0.86
M-Score: -2.80
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 5.32
MDAS's Operating margin (%) is ranked higher than
51% of the 1724 Companies
in the Global Health Information Services industry.

( Industry Median: 5.00 vs. MDAS: 5.32 )
Ranked among companies with meaningful Operating margin (%) only.
MDAS' s 10-Year Operating margin (%) Range
Min: -4.99  Med: 13.34 Max: 17.56
Current: 5.32
-4.99
17.56
Net-margin (%) -3.36
MDAS's Net-margin (%) is ranked lower than
70% of the 1724 Companies
in the Global Health Information Services industry.

( Industry Median: 3.15 vs. MDAS: -3.36 )
Ranked among companies with meaningful Net-margin (%) only.
MDAS' s 10-Year Net-margin (%) Range
Min: -8.21  Med: 3.05 Max: 16.69
Current: -3.36
-8.21
16.69
ROE (%) -5.28
MDAS's ROE (%) is ranked lower than
73% of the 1678 Companies
in the Global Health Information Services industry.

( Industry Median: 5.86 vs. MDAS: -5.28 )
Ranked among companies with meaningful ROE (%) only.
MDAS' s 10-Year ROE (%) Range
Min: -36.47  Med: -3.63 Max: 5.94
Current: -5.28
-36.47
5.94
ROA (%) -1.48
MDAS's ROA (%) is ranked lower than
68% of the 1762 Companies
in the Global Health Information Services industry.

( Industry Median: 3.06 vs. MDAS: -1.48 )
Ranked among companies with meaningful ROA (%) only.
MDAS' s 10-Year ROA (%) Range
Min: -2.45  Med: 1.67 Max: 14.99
Current: -1.48
-2.45
14.99
ROC (Joel Greenblatt) (%) 24.12
MDAS's ROC (Joel Greenblatt) (%) is ranked higher than
50% of the 1736 Companies
in the Global Health Information Services industry.

( Industry Median: 22.95 vs. MDAS: 24.12 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MDAS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -27.4  Med: 57.09 Max: 139.34
Current: 24.12
-27.4
139.34
Revenue Growth (3Y)(%) 6.10
MDAS's Revenue Growth (3Y)(%) is ranked higher than
54% of the 1302 Companies
in the Global Health Information Services industry.

( Industry Median: 5.20 vs. MDAS: 6.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MDAS' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0  Med: 6.10 Max: 23.6
Current: 6.1
0
23.6
EBITDA Growth (3Y)(%) -0.40
MDAS's EBITDA Growth (3Y)(%) is ranked lower than
62% of the 1046 Companies
in the Global Health Information Services industry.

( Industry Median: 6.90 vs. MDAS: -0.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MDAS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: -0.40 Max: 72.3
Current: -0.4
0
72.3
EPS Growth (3Y)(%) 8.00
MDAS's EPS Growth (3Y)(%) is ranked higher than
54% of the 972 Companies
in the Global Health Information Services industry.

( Industry Median: 6.10 vs. MDAS: 8.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MDAS' s 10-Year EPS Growth (3Y)(%) Range
Min: 0  Med: -19.70 Max: 8
Current: 8
0
8
» MDAS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

MDAS Guru Trades in Q2 2014

Paul Tudor Jones 9,800 sh (New)
Joel Greenblatt 52,010 sh (+52.08%)
Mario Gabelli 11,500 sh (unchged)
Steven Cohen 245,600 sh (unchged)
Jim Simons Sold Out
» More
Q3 2014

MDAS Guru Trades in Q3 2014

Paul Tudor Jones 25,815 sh (+163.42%)
Steven Cohen 538,000 sh (+119.06%)
Mario Gabelli 12,500 sh (+8.70%)
Joel Greenblatt 56,371 sh (+8.38%)
» More
Q4 2014

MDAS Guru Trades in Q4 2014

Paul Tudor Jones 55,316 sh (+114.28%)
Joel Greenblatt 58,929 sh (+4.54%)
Mario Gabelli 12,500 sh (unchged)
Steven Cohen Sold Out
» More
Q1 2015

MDAS Guru Trades in Q1 2015

Mario Gabelli 10,500 sh (-16.00%)
Paul Tudor Jones 21,801 sh (-60.59%)
Joel Greenblatt 16,953 sh (-71.23%)
» More
» Details

Insider Trades

Latest Guru Trades with MDAS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 16.69
MDAS's Forward P/E is ranked higher than
64% of the 529 Companies
in the Global Health Information Services industry.

( Industry Median: 19.69 vs. MDAS: 16.69 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 2.91
MDAS's P/B is ranked lower than
51% of the 1614 Companies
in the Global Health Information Services industry.

( Industry Median: 2.71 vs. MDAS: 2.91 )
Ranked among companies with meaningful P/B only.
MDAS' s 10-Year P/B Range
Min: 1.26  Med: 2.56 Max: 4.39
Current: 2.91
1.26
4.39
P/S 1.73
MDAS's P/S is ranked higher than
56% of the 1701 Companies
in the Global Health Information Services industry.

( Industry Median: 2.19 vs. MDAS: 1.73 )
Ranked among companies with meaningful P/S only.
MDAS' s 10-Year P/S Range
Min: 0.92  Med: 1.88 Max: 4.22
Current: 1.73
0.92
4.22
PFCF 14.34
MDAS's PFCF is ranked higher than
77% of the 812 Companies
in the Global Health Information Services industry.

( Industry Median: 25.40 vs. MDAS: 14.34 )
Ranked among companies with meaningful PFCF only.
MDAS' s 10-Year PFCF Range
Min: 5.2  Med: 15.19 Max: 50.8
Current: 14.34
5.2
50.8
POCF 8.41
MDAS's POCF is ranked higher than
83% of the 1012 Companies
in the Global Health Information Services industry.

( Industry Median: 18.40 vs. MDAS: 8.41 )
Ranked among companies with meaningful POCF only.
MDAS' s 10-Year POCF Range
Min: 3.83  Med: 8.87 Max: 34.86
Current: 8.41
3.83
34.86
EV-to-EBIT 54.95
MDAS's EV-to-EBIT is ranked lower than
80% of the 1145 Companies
in the Global Health Information Services industry.

( Industry Median: 17.09 vs. MDAS: 54.95 )
Ranked among companies with meaningful EV-to-EBIT only.
MDAS' s 10-Year EV-to-EBIT Range
Min: -107.8  Med: 25.60 Max: 57.5
Current: 54.95
-107.8
57.5
Current Ratio 0.71
MDAS's Current Ratio is ranked lower than
92% of the 1590 Companies
in the Global Health Information Services industry.

( Industry Median: 2.08 vs. MDAS: 0.71 )
Ranked among companies with meaningful Current Ratio only.
MDAS' s 10-Year Current Ratio Range
Min: 0.55  Med: 0.71 Max: 2.77
Current: 0.71
0.55
2.77
Quick Ratio 0.71
MDAS's Quick Ratio is ranked lower than
90% of the 1590 Companies
in the Global Health Information Services industry.

( Industry Median: 1.94 vs. MDAS: 0.71 )
Ranked among companies with meaningful Quick Ratio only.
MDAS' s 10-Year Quick Ratio Range
Min: 0.55  Med: 0.71 Max: 2.77
Current: 0.71
0.55
2.77
Days Sales Outstanding 61.56
MDAS's Days Sales Outstanding is ranked higher than
58% of the 1486 Companies
in the Global Health Information Services industry.

( Industry Median: 69.02 vs. MDAS: 61.56 )
Ranked among companies with meaningful Days Sales Outstanding only.
MDAS' s 10-Year Days Sales Outstanding Range
Min: 47.01  Med: 64.98 Max: 93.29
Current: 61.56
47.01
93.29

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.92
MDAS's Price/Projected FCF is ranked higher than
82% of the 794 Companies
in the Global Health Information Services industry.

( Industry Median: 1.82 vs. MDAS: 0.92 )
Ranked among companies with meaningful Price/Projected FCF only.
MDAS' s 10-Year Price/Projected FCF Range
Min: 0.78  Med: 1.08 Max: 2.01
Current: 0.92
0.78
2.01
Price/Median PS Value 0.93
MDAS's Price/Median PS Value is ranked higher than
73% of the 1546 Companies
in the Global Health Information Services industry.

( Industry Median: 1.21 vs. MDAS: 0.93 )
Ranked among companies with meaningful Price/Median PS Value only.
MDAS' s 10-Year Price/Median PS Value Range
Min: 0.49  Med: 0.97 Max: 2.07
Current: 0.93
0.49
2.07
Earnings Yield (Greenblatt) (%) 1.85
MDAS's Earnings Yield (Greenblatt) (%) is ranked lower than
54% of the 1696 Companies
in the Global Health Information Services industry.

( Industry Median: 2.70 vs. MDAS: 1.85 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MDAS' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 1.7  Med: 3.80 Max: 5.1
Current: 1.85
1.7
5.1
Forward Rate of Return (Yacktman) (%) 36.82
MDAS's Forward Rate of Return (Yacktman) (%) is ranked higher than
92% of the 668 Companies
in the Global Health Information Services industry.

( Industry Median: 10.77 vs. MDAS: 36.82 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MDAS' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 3.3  Med: 14.35 Max: 37.7
Current: 36.82
3.3
37.7

Business Description

Industry: Application Software » Health Information Services
Compare: » details
Traded in other countries:58M.Germany,
MedAssets Inc was incorporated in 1999. It is a financial and performance improvement company providing technology-enabled products and services that, together, help mitigate the increasing financial challenges faced by hospitals, health systems, and other non-acute healthcare providers. Its solutions are designed to reduce the total cost of care delivery, enhance operational efficiency, align clinical delivery of physicians and staff to advance care coordination, and improve revenue performance mainly for hospitals and health systems. The Company's solutions integrate with its clients' existing operations and enterprise software systems, and require minimal upfront costs or capital expenditures for its clients. Its technology-enabled solutions are delivered through company-hosted software, sometimes referred to as software as a service or Web-based applications, supported by implementation, process improvement consulting and outsourced services, as well as enterprise-wide sales and client management support. The Company manages its business through two business segments, Spend and Clinical Resource Management (CM) and Revenue Cycle Management (RCM). Within the SCM segment it provides a comprehensive suite of cost management services, supply chain analytics and data capabilities that help its clients reduce their total cost of care delivery, enhance their operational efficiency and align their clinicians' delivery of care with advance care coordination. Its solutions lower operating costs through compliance to its strategic sourcing of supplies and purchased services at discounted prices, supply chain outsourcing and procurement services capabilities. It also help to improve care processes and reduce care variations through the use of its clinical and process improvement consulting services, workforce optimization solutions and business analytics and intelligence tools. The Company's RCM segment is a provider of revenue cycle management solutions to healthcare providers, mainly hospitals and health systems. It provides SaaS or Web-based software and technology-enabled services designed to improve revenue performance for healthcare organizations through patient access and financial responsibility, clinical documentation, charge capture and revenue integrity, pricing analysis, claims processing and denials management, payor contract management, extended business office revenue recovery, accounts receivable services and outsourcing. As of December 31, 2013, the Company's client base included more than 4,400 acute care hospitals and approximately 122,000 ancillary or non-acute provider locations. The Company competes with Allscripts Corporation, Epic Systems Corporation, McKesson Corporation, Siemens AG; Accenture Ltd., Accretive Health, Inc., Deloitte & Touche LLP, Ernst & Young LLP, Craneware Inc., Emdeon Inc. and among others. The Company is subject to federal and state laws and regulations designed to protect patients, government
» More Articles for MDAS

Headlines

Articles On GuruFocus.com
Litespeed Management adds to its stake in MedAssets Jul 07 2015 
Weekly CEO Buys Highlight: APD, MDAS, PNNT, MDU, SRV Feb 23 2015 
Weekly CEO Sells Highlight: Amazon.com Inc, Atmel Corporation, Monolithic Power Systems Inc, MedAsse Nov 10 2013 
Steven Cohen Increases Two High-Growth Positions - OCZ Technology and MedAssets Inc. Apr 17 2012 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 9,000 Shares Mar 08 2011 
MEDASSETS, INC. Reports Operating Results (10-K) Mar 01 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Feb 09 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Jan 05 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Dec 08 2010 
MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 40,000 Shares Dec 01 2010 

More From Other Websites
Edited Transcript of MDAS earnings conference call or presentation 29-Jul-15 9:00pm GMT Jul 30 2015
MedAssets beats Street 2Q forecasts Jul 29 2015
MedAssets beats Street 2Q forecasts Jul 29 2015
4:25 pm MedAssets beats by $0.04, beats on revs; raises FY15 EPS and rev guidance Jul 29 2015
MedAssets Reports Second Quarter and Six-Month 2015 Financial Results Jul 29 2015
MEDASSETS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 29 2015
MedAssets Reports Second Quarter and Six-Month 2015 Financial Results Jul 29 2015
Buy MedAssets as It Breaks Resistance Jul 13 2015
MedAssets to Report Second Quarter 2015 Financial Results on Wednesday, July 29th Jul 08 2015
MedAssets to Report Second Quarter 2015 Financial Results on Wednesday, July 29th Jul 08 2015
MEDASSETS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial... Jun 22 2015
Kevin M. Twomey Joins MedAssets Board of Directors Jun 22 2015
Kevin M. Twomey Joins MedAssets Board of Directors Jun 22 2015
Watch These After-Hours Movers Today Jun 19 2015
Coverage initiated on MedAssets by Oppenheimer Jun 18 2015
Edited Transcript of MSON earnings conference call or presentation 7-May-15 8:30pm GMT Jun 17 2015
MEDASSETS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 15 2015
MedAssets Announces Call for Exhibitors for 2015 Technology & Innovation Expo Jun 05 2015
MedAssets Announces Call for Exhibitors for 2015 Technology & Innovation Expo Jun 05 2015
MedAssets Expands Partnership with Jackson Health System - Analyst Blog Jun 01 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK